Skip to content

Clinical trials

Observational Mucopolysaccharidosis II trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mucopolysaccharidosis II Phase: Observational Country / region: United States Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20093
20111
20121
20131
20141
20171
20181
20191
20201
20212
20223

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated4
Active, not recruiting2
Enrolling by invitation1
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shire6
REGENXBIO Inc.3
Albert Einstein College of Medicine1
Denali Therapeutics Inc.1
Duke University1
National MPS Society1
RTI International1
Sangamo Therapeutics1
University of California, San Francisco1
University of Chicago1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mucopolysaccharidosis II18
Sudden Infant Death9
Mucopolysaccharidosis I7
Mucopolysaccharidosis VI7
Mucopolysaccharidoses6
Mucopolysaccharidosis IV5
Mucopolysaccharidosis VII4
Lysosomal Storage Diseases3
Mucopolysaccharidosis III3
Wolman Disease3

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.